1.1 This submission on the Misuse of Drugs (Pseudoephedrine) Amendment Bill[1] is made by The New Zealand Initiative (the Initiative), a Wellington-based think tank supported primarily by major New Zealand businesses. In combination, our members employ more than 150,000 people. Read more

Requiring Medsafe approval for pharmaceuticals already approved by at least two trustworthy overseas regulators makes little sense. Foreign pharmaceutical approval agencies are well-resourced. Read more

As the nation prepares to vote on 14 October, the sentiment across New Zealand is one of frustration and concern. Skyrocketing living costs, unaffordable housing, strained healthcare, and a growing educational gap are the voices of a country looking for change. Read more

New Zealand's general medical practitioners (GPs) are facing a crisis, with a workforce shortage set to worsen over the next decade unless immediate action is taken to support workforce expansion and development. The health of all New Zealanders and the delivery of top-tier healthcare heavily relies on community-based medical care, mainly provided by Specialist GPs and multi-disciplinary health care teams. The introduction of an "accountability-free capitation" has seemingly driven a decline in the hours GPs work by creating a financial incentive to minimize patient service costs, and analyses indicate a significant decrease in the GP to population ratio, and a decline in GP work hours. Read more

Pharmac is often criticised for not funding enough new medicines and for being too slow to determine which ones it will fund. However, being slow and focused is not proof of being too slow or too focused. Read more